Combination bacteriolytic therapy for the treatment of experimental tumors - Wikidata - awgldk - TriplyDB

Combination bacteriolytic therapy for the treatment of experimental tumors

Combination bacteriolytic therapy for the treatment of experimental tumors

http://www.wikidata.org/entity/Q24555050

about

Can engineered bacteria help control cancer?Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria Bacterial therapies: completing the cancer treatment toolbox Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress Strains, Mechanism, and Perspective: Salmonella-Based Cancer Therapy Combined bacterial and viral treatment: a novel anticancer strategy Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines.One-step enzymatic modification of the cell surface redirects cellular cytotoxicity and parasite tropism.Targeted Cancer Therapy Using Engineered Salmonella typhimurium Exploiting tumour hypoxia in cancer treatment Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.Can oncology recapitulate paleontology? Lessons from species extinctions Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium.Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.Using archaeal genomics to fight global warming and clostridia to fight cancer.Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT Synthetic biology approaches in drug discovery and pharmaceutical biotechnology.Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene.Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.Thermostable direct hemolysin downregulates human colon carcinoma cell proliferation with the involvement of E-cadherin, and β-catenin/Tcf-4 signaling.Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer.Bacteriolytic therapy of experimental pancreatic carcinoma.Synthetic biology for translational research.Bacterial immunotherapy of gastrointestinal tumors.Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins.Clostridia in cancer therapy.A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy (+)-Discodermolide: Total Synthesis, Construction of Novel Analogues, and Biological Evaluation Cancer and the microbiota.Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity.TcsL is an essential virulence factor in Clostridium sordellii ATCC 9714 A robust approach to enhance tumor-selective accumulation of nanoparticles.MRI-monitored intra-tumoral injection of iron-oxide labeled Clostridium novyi-NT anaerobes in pancreatic carcinoma mouse model.Microorganisms and cancer: quest for a therapy.Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium Multilayered genetic safeguards limit growth of microorganisms to defined environments

P2860

Q24555059-C55E390E-9B8A-4683-BCC1-0573FFA71FBF Q24569648-4D881DEE-5AA9-4267-8FEC-C0218C6EDD70 Q24646711-3BB17D19-FA5A-49D5-B2EA-144F02284A40 Q26745551-A1869838-D4D5-4988-948D-2D667380958A Q26748794-D3050819-18E8-4118-9E53-4C73B1E21781 Q26773180-9E274DE1-F87E-434E-887A-92BCF1C6C67E Q27323196-13E44D03-3D8A-4C4C-A583-7190066953F2 Q27339549-26EDB665-3DAC-45D2-BB05-76B3BBCBEDD7 Q28069354-88549D3D-28BE-47A8-9124-7A21BBA9B6C7 Q28264146-02414454-9F88-438C-8F76-17EB80550B9C Q28387398-CD22C49D-73A2-4A02-A48A-FB3CAAD69D99 Q28607703-B031F95D-ED21-4FD2-8C32-29D56ADF39F6 Q30491729-1BC0641B-BE1F-40DE-A958-1C5B442F5D79 Q30677182-42EA87FE-63C9-4DE1-9D87-3248056F185F Q33269161-AC8F1DEB-FA5E-43DD-AFDC-0256FB4BF612 Q33302104-6939FC0D-0667-4D61-A79B-97488E59ABA6 Q33557182-B224441A-61A5-4D92-8A14-97956C393A0B Q33557865-873BC1F1-2221-40A9-8A97-93E547F73710 Q33688369-449B27F8-C7F7-4F9C-B183-E3567DCDE9E2 Q33691013-A67035DA-F9E9-4ACD-9CC9-AB6ECDE78D9F Q33731187-212E1E61-3A0D-40AD-ABDB-E8BA6F66C188 Q33756746-D4024673-7F07-44AF-ACB9-D9478CD59F56 Q33762809-0A6D58C4-8CED-485E-9F00-963A839C0DD9 Q33916259-124B6E37-A5AC-4DA4-B945-DF513C3FA55E Q33925546-98E7A9A7-EEF9-45CB-BAA1-CD013218DCEC Q34018256-649F17DA-CA05-4765-AFDC-F2702C822EE2 Q34073961-6201ECA5-E869-4112-9663-BFF881ADBF4B Q34242204-D04A4B2B-B77C-47B2-9805-C2A7E5F7B9D0 Q34301980-A8E43F92-CDB0-4E92-956C-A275B7E3289D Q34307573-F1F7C5F5-5672-4700-9E6F-1FD991B9E65B Q34315760-6BC70609-AF56-4935-9F09-B2992EE612C0 Q34347107-4C5F21C4-0133-4B4C-9849-7F2EEFA30B22 Q34470083-04DEFBAF-9E82-4B8C-8241-DEF0F8664EF7 Q34620886-DFC0CA28-B49E-4E78-91B2-A1849DD5946C Q34739730-351445DA-98A5-4E11-8216-8F78D6D83ACB Q34754720-7BFD5C02-6C19-45A0-BCD0-C75C63289F76 Q34790492-C67C8CBA-23B9-449D-8CAD-84DF4CF88B1B Q34983790-A7018D43-720F-4402-9535-C587656FEA22 Q34988082-1291C6A1-A267-4D4A-AC06-C941785BF6E4 Q35088968-3CAA8622-A653-41EF-AAA6-49E43F24286C

P2860

Combination bacteriolytic therapy for the treatment of experimental tumors

http://www.wikidata.org/entity/Q24555050

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Combination bacteriolytic therapy for the treatment of experimental tumors

@ast

Combination bacteriolytic therapy for the treatment of experimental tumors

@en

Combination bacteriolytic therapy for the treatment of experimental tumors

@nl

type

label

Combination bacteriolytic therapy for the treatment of experimental tumors

@ast

Combination bacteriolytic therapy for the treatment of experimental tumors

@en

Combination bacteriolytic therapy for the treatment of experimental tumors

@nl

prefLabel

Combination bacteriolytic therapy for the treatment of experimental tumors

@ast

Combination bacteriolytic therapy for the treatment of experimental tumors

@en

Combination bacteriolytic therapy for the treatment of experimental tumors

@nl

P1433

Q24555050-55F43F84-C4EB-4613-8611-C14E2F0CE8AB

P1476

Q24555050-949C114F-3098-4362-B49D-D616D2143368

P2093

Q24555050-84708564-669B-4C76-A5FA-03E0B0F17D41

Q24555050-B8D2BE3D-EF49-42A8-B3FF-6F0A8664A1D2

Q24555050-F41948B6-A3CD-4DDC-AAA5-55F1711B7734

P2860

Q24555050-0E79A7DB-F9E3-4A05-9443-3921C390ED0D

Q24555050-13D67E35-4916-4303-9F83-917F53494BC9

Q24555050-1E6C9772-5E62-4652-ABA1-E50E5BC4D86D

Q24555050-225F2D40-10E0-4626-8506-535B3B5C0A87

Q24555050-2443D7EB-F512-4C02-AEF9-2818A3241982

Q24555050-45ECE750-5228-49F9-81F5-D5F750B4215C

Q24555050-58AE5340-D5C7-4527-BCBC-33856DCAB6AF

Q24555050-63FA4791-CFAD-4385-85E5-4C2D76BB6002

Q24555050-8CEAE04C-FBE0-47FC-A84A-BBC2939FD617

Q24555050-9229ED5C-8870-4107-91F3-EF861B60471D

P304

Q24555050-6A3069B0-6972-463B-B0DA-C82AD9BBCA12

P31

Q24555050-99B6B869-80B8-4826-A039-F8B7E650AED9

P3181

Q24555050-5BCFD88B-E858-4BC6-A54B-000D0F862CF3

P356

Q24555050-AE6DAC2F-BE10-4B9E-931A-2D5EFDCF6434

P407

Q24555050-4C182031-08F6-4E06-AB5D-BA817D9B3235

P433

Q24555050-439A38DC-953C-4236-A7F7-0846015DA21C

P478

Q24555050-5D3F2D86-1904-4456-A74F-809AAA7CC467

P50

Q24555050-6122944C-C80E-4A08-8BD6-332A5A95427B

Q24555050-8564FFCB-77F9-411F-9924-7B797FA18977

P577

Q24555050-29D0BE2B-7395-401C-9E68-5964F99C6929

P5875

Q24555050-595F4BC7-C7FD-4C44-A3B5-53FF39CD18B1

P698

Q24555050-0D762BF6-DD5D-4045-B3B5-4EBA60D2727B

P932

Q24555050-6BDA1AC2-AB84-4AEE-9C23-1128667659E6

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Combination bacteriolytic therapy for the treatment of experimental tumors

@en

P2093

C Bettegowda

http://www.w3.org/2001/XMLSchema#string

D L Huso

http://www.w3.org/2001/XMLSchema#string

L H Dang

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas.

Use of preferentially replicating bacteria for the treatment of cancer.

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.

Delivery of molecular and cellular medicine to solid tumors.

Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration.

Acute tumor lysis syndrome.

Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile.

Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.

Phylogenetic analysis of phospholipase C genes from Clostridium perfringens types A to E and Clostridium novyi.

Molecular genetics and pathogenesis of Clostridium perfringens.

P304

15155-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2299439

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.251543698

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth W Kinzler

Bert Vogelstein

P577

2001-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11630774

http://www.w3.org/2001/XMLSchema#string

P698

11724950

http://www.w3.org/2001/XMLSchema#string

P932

64999

http://www.w3.org/2001/XMLSchema#string